SCHEMBL8487643

SCHEMBL8487643

Fc1ccc(Nc2ncnc3cnc(N4CCC5(CC4)CNC5)nc23)cc1Cl

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 13/20 0.63
ERBB2 P04626 10/20 0.63
MAPT P10636 1/20 0.63
HPGD P15428 1/20 0.54
HTT P42858 1/20 0.54
GRM1 Q13255 1/20 0.46
BCL6 P41182 2/20 0.44
ERBB4 Q15303 4/20 0.42
BRAF P15056 4/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
JAK3 P52333 1/20 0.41
AURKA O14965 1/20 0.41
INSR P06213 1/20 0.41
FBP1 P09467 1/20 0.41
PDGFRB P09619 1/20 0.41
FLT4 P35916 1/20 0.41
KDR P35968 1/20 0.41
CLK1 P49759 1/20 0.41
EPHB4 P54760 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8483882 0.93 EGFR (0.63) EGFRERBB2MAPTHPGDHTT
SCHEMBL8488643 0.89 EGFR (0.65) EGFRERBB2MAPTHPGDHTT
SCHEMBL8488324 0.87 EGFR (0.60) EGFRERBB2MAPTHPGDHTT
SCHEMBL8316917 0.86 EGFR (0.71) EGFRERBB2MAPTHPGDHTT
SCHEMBL8484324 0.86 EGFR (0.62) EGFRERBB2MAPTHPGDHTT
SCHEMBL6361454 0.86 EGFR (0.66) EGFRERBB2MAPTHPGDHTT
SCHEMBL8487772 0.86 EGFR (0.62) EGFRERBB2MAPTHPGDHTT
SCHEMBL8485708 0.86 EGFR (0.61) EGFRERBB2MAPTHPGDHTT
SCHEMBL6998251 0.86 EGFR (0.70) EGFRERBB2MAPTHPGDHTT
SCHEMBL6990982 0.86 EGFR (0.70) EGFRERBB2MAPTHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977102-A INHIBITORY EFFECT ON SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES OR EPIDERMAL GROWTH FACTOR; ANTITUMOR,-CARCINOGENIC, -METASTASIS,-PROLIFERATION AGENTS AND -INFLAMMATORY AGENTS; PSORIASIS; ANGIOGENESIS INHIBITORS; IMMUNOLOGY; DR. KARL THOMAE GMBH (DE) 1999-11-02 US disclosed
EP-0885227-A1 PYRIMIDO 5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION Dr. Karl Thomae GmbH (DE) 1998-12-23 EP disclosed
WO-1997032882-A1 PYRIMIDO[5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION DR. KARL THOMAE GMBH (DE) 1997-09-12 WO disclosed